• Monthly News Roundup - January 2026

    FDA OKs Darzalex Faspro Combo for Newly Diagnosed Multiple Myeloma
    The FDA has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for adults with newly diagnosed...

Follow @PharmaIndustry_ on Twitter!